Biological
A new report issued by leaders in international health says the world may face great risk from pathogens, including a rapidly moving, highly lethal pandemic projected to kill 50 to 80 million people and wiping out nearly 5 percent of the world’s economy.
High-impact respiratory pathogens, such... Read More »
The Centers for Disease Control and Prevention’s (CDC) Center for Global Health was designated as a Collaborating Center for Biosafety and Biosecurity by the Pan American Health Organization/World Health Organization (PAHO/WHO).
The designation -- the first awarded to a CDC/WHO collaborating... Read More »
The Sept. 14 gas explosion that stoked a fire at a Russian bioweapons facility in Siberia where viruses and bacteria including smallpox, Ebola and anthrax are stored reminded the world that humans are only one catastrophic biological event away from a pandemic that could kill tens of millions of... Read More »
There’s a new word on the street that packs a lot of punch: cyberbiosecurity, which is introducing a host of new multilayered threats to biodefense.
Members of the newly named Bipartisan Commission on Biodefense — formerly the Blue Ribbon Study Panel on Biodefense — last week sought a... Read More »
Emergent BioSolutions Inc. said Tuesday it was awarded a contract for its smallpox vaccine from the Office of the Assistant Secretary for Preparedness and Response (ASPR) in the U.S. Department of Health and Human Services (HHS) valued at approximately $2 billion over 10 years.
The contract... Read More »
The Department of Health and Human Services’ (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) has contracted with a firm to aid a burn imaging device’s development.
The two-year, $27.3 million contract with SpectralMD, Inc., of Dallas, Texas, advances the... Read More »
A new study published in the journal iScience reveals that the already Food and Drug Administration-approved drug nitazoxanide may hold promise as an Ebola treatment.
Nitazoxanide, or NTZ, is not traditionally used for Ebola treatment. Rather, it is a treatment for gastrointestinal infections... Read More »
U.S. House Energy and Commerce Committee leaders have written to the U.S. Comptroller General requesting that the Government Accountability Office examine the Department of Homeland Security’s (DHS) new biodetection technology system known as BioDetection 21.
The BioDetection 21 pilot program... Read More »
With research on hold at its Fort Detrick, Md., location following a federal-government-ordered shutdown, the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) this week began what it deems “a major re-set of its biological safety program,” which provides leading-edge... Read More »
The U.S. Government Accountability Office (GAO) recently identified several challenges related to the nation’s ability to detect and respond to biological events. These hurdles transcend what any one federal department or agency can individually address.
The GAO found four precarious areas,... Read More »
U.S. Rep. Jaime Herrera Beutler (R-WA) was awarded Wednesday the 2019 Congressional Biosecurity Champion Award from the Alliance for Biosecurity.
The annual award recognizes Congressional members that work to improve the country’s capabilities to prevent and combat chemical, biological,... Read More »
The Biomedical Advanced Research and Development Authority (BARDA) exercised its first $261 million contract option with Emergent BioSolutions Inc. to procure its next-generation anthrax vaccine known as AV7909 for delivery into the Strategic National Stockpile (SNS) over 12 months, the company... Read More »
The U.S. Department of Defense (DoD) has awarded SIGA Technologies a contract valued at up to $19.5 million, with an initial award of $12.4 million, to advance work that could provide a label expansion for TPOXX, a drug used to treat smallpox.
This multi-year contract, which was announced this... Read More »
A new amendment advanced by the House last week will require the Inspector General of the Department of Defense (DOD) to investigate claims that the DOD weaponized Lyme disease in ticks and other insects from 1950 to 1975.
The amendment was introduced by U.S. Rep. Chris Smith (R-NJ), who has... Read More »
An effort similar to the Manhattan Project — in which American-led R&D produced the first nuclear weapons during World War II — is needed now in defense against the growing global threats posed by infectious diseases and bioterrorism, sources said Thursday during a Blue Ribbon Study Panel on... Read More »
The House this week advanced a measure introduced by U.S. Rep. John Ratcliffe (R-TX), following similar successful efforts in the Senate, and raising the potential to prosecute the possession of biological toxins.
The Effective Prosecution of Possession of Biological Toxins and Agents Act of... Read More »
With a focus on biological threats to the United States and a new, public-private effort to counter them, the Blue Ribbon Study Panel on Biodefense will host its first public meeting in New York City this week.
Their main topic of discussion will be ‘A Manhattan Project for Biodefense’ -- a... Read More »
Nuclear Threat Initiative (NTI) personnel recently joined a series of partners in addressing the increasing risks of a catastrophic biological event.
Citing such factors as rapid technological advances, an increasingly interconnected world with health security challenges, ongoing global... Read More »
Defense Advanced Research Projects Agency (DARPA) officials said the 2019 Indianapolis 500 aided the department’s nuclear, biological and chemical threat detection process.
During the event, an advanced network of sensors kept continued vigilance, providing security real-time awareness of any... Read More »
The Government Accountability Office (GAO) recently reviewed reports issued from December 2009 through March 2019 on various biological threats and biodefense efforts.
The agency concluded many challenges remain.
GAO concluded in 2011 that there was no broad, integrated national strategy and... Read More »
Dr. Asha George understands firsthand the threats biological agents can cause. George, who is executive director of the Blue Ribbon Study Panel on Biodefense, served in Operation Desert Storm. She knows what it’s like to be standing on the battlefield wondering whether antimicrobial resistant... Read More »
The Pandemic and All-Hazards Preparedness and Advancing (PAHPA) Innovation Act, S. 1379, became law on Monday with the president’s signature, prompting accolades from national stakeholders, company executives and federal lawmakers.
The far-reaching law ensures the United States will be better... Read More »
As a means of addressing the rising threat of bioterrorism, the House Judiciary Committee has approved a bill criminalizing possession of certain deadly substances.
Reps. John Ratcliffe (R-TX) and Kathleen Rice (D-NY) introduced the Effective Prosecution of Possession of Biological Toxins and... Read More »
A new study suggests that comprehensive health system planning can stymie the effects of a deliberate release of smallpox in a city, a nightmare scenario for public health officials.
The research, which was published today in the online journal PLOS One, said that if a health system response is... Read More »
The current Ebola outbreak in the Democratic Republic of the Congo (DRC) risks spreading to Rwanda, Uganda, Ethiopia, and South Sudan, according to testimony by public health experts on Tuesday before the U.S. House Committee on Foreign Affairs.
The outbreak in the DRC began in August 2018 and... Read More »
The Blue Ribbon Study Panel on Biodefense, the Alliance for Biosecurity, and the Trust for America’s Health on Wednesday applauded the overdue reauthorization of the nation’s all-hazards preparedness and response law addressing public health threats, whether naturally occurring or... Read More »
The U.S. Food and Drug Administration (FDA) has granted Emergent BioSolutions Inc. approval to change the storage conditions and manufacturing facility for its oral cholera vaccine, Vaxchora.
Specifically, the FDA's approval of the Prior Approval Supplement (PAS) submitted by the company... Read More »
The U.S. House of Representatives on Tuesday approved the bipartisan Pandemic and All-Hazards Preparedness and Advancing (PAHPA) Innovation Act of 2019, which now heads to President Donald Trump’s desk for his signature to make it law.
S. 1379, sponsored by U.S. Sen. Richard Burr (R-NC) on May... Read More »
The U.S. Department of Health and Human Services (HHS) has awarded a 10-year, $535 million contract to Emergent BioSolutions Inc. for the supply of Vaccinia Immune Globulin Intravenous (VIGIV) into the U.S. Strategic National Stockpile in support of smallpox preparedness.
VIGIV is the only... Read More »
There have been 971 cases of measles in the United States thus far in 2019, according to a new report by the Centers for Disease Control and Prevention (CDC).
This is the highest number of cases in the United States since 1992 when 963 cases were reported for the whole year. The CDC has been... Read More »
The United States’ ability to manage health emergencies has steadily improved over the last six years, according to a nationwide index of health security.
The 2019 National Health Security Preparedness Index, supported by the Robert Wood Johnson Foundation (RWJF), analyzes 129 different... Read More »
The full U.S. Senate on Thursday approved bipartisan legislation that would reauthorize the nation’s all-hazards preparedness and response law.
“I am pleased my Senate colleagues joined me in supporting this legislation that ensures America’s biodefenses are ready for the public health... Read More »
The Biomedical Advanced Research and Development Authority (BARDA) will begin procuring Emergent BioSolutions’ anthrax vaccine into the Strategic National Stockpile (SNS) to strengthen U.S. preparedness in the event of a public health threat, the company said on Wednesday.
Emergent... Read More »
The U.S. Senate is fast tracking bipartisan legislation to reauthorize the nation’s all-hazards preparedness and response law, according to the Alliance for Biosecurity.
U.S. Sens. Richard Burr (R-NC) and Bob Casey (D-PA) on May 8 sponsored S. 1379, which has been referred to the U.S. Senate... Read More »
The Food and Drug Administration (FDA) recently made final guidance available to government stakeholders on testing to extend the expiration date of stockpiled medical countermeasures (MCMs) used during public health emergency preparedness and response for anthrax exposure.
Stockpiles of... Read More »
